Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Dems call out Coburn on food safety

This article was originally published in The Tan Sheet

Executive Summary

Democrats on the House Oversight and Investigations Subcommittee call on Sen. Tom Coburn, R-Okla., to remove his hold on S. 510, the food safety legislation pending in the Senate. Coburn is "holding food safety legislation hostage," said Henry Waxman, Energy and Commerce Committee chairman. Republicans are trying to prevent any legislation from passing, explained Rep. Edward Markey, D-Mass. Ranking Republican Michael Burgess, R-Texas, attempted to read a statement from Coburn indicating Senate Majority Leader Harry Reid is delaying S. 510 during a Sept. 22 hearing, but Waxman turned off Burgess' microphone. Also during the hearing, FDA Principal Deputy Commissioner Joshua Sharfstein urged Congress to pass the bill, saying it will "do a lot more than help make eggs safer.

You may also be interested in...



More GMP Warnings, Import Alerts For OTC Firms As US FDA Capped List Of Uninspected Facilities

Most of the foreign OTC drug firms targeted in latest warnings FDA published, including the GUM oral care brand manufacturer, were placed on import alert due to GMP violations. Each was inspected by FDA during June, July or May 2019, when the agency was wrapping up an initiative to inspect all previously uninspected drug manufacturers.

AbbVie/Allergan Merger Edges Closer To FTC Clearance

AstraZeneca will reacquire Allergan's investigational IL-23 inhibitor brazikumab, and Nestle is to buy its GI drug Zenpep, which had nine-month revenue of $208m.

Another Sterilization Plant Closes For Upgrades; FDA Monitoring Situation For Device Shortage

The US agency is engaged with an ethylene oxide (EtO) sterilizer in Illinois that has temporarily closed to determine if there are any potential risks to the medical device supply chain. While the plant shut down about a month ago, regulators have only recently been made aware of the decision, which resulted from a law passed last year by the state legislature.

Topics

UsernamePublicRestriction

Register

PS104536

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel